| 1 |
Cell-penetrating antagomir for acute myocardial infarction (nonclinical study) |
| Gene & Nucleic acids |
Myocardial infarction |
miRNA (miR-145 억제) |
Preclinical |
RegenInnopharm Inc |
RS-2024-00333652 |
|
| 2 |
GGT-001, Pulmonary Arterial Hypertension AAV Gene Therapy |
| Gene & Nucleic acids |
Pulmonary hypertension |
FGF12 |
Lead |
GluGene Therapeutics |
RS-2023-00217737 |
|
| 3 |
Project Cell penetrating miRNA-based therapy for acute myocardial infarction |
| Gene & Nucleic acids |
Acute heart failure |
miRNA (miR-A, 128-3p, 34a-5p, B, 203a-3p) |
Candidate |
StemMeditech Inc. |
HN21C0741 |
|
| 4 |
GB107, Gene therapy for ischemic limb disease via new expression vector and PT1 technology |
| Gene & Nucleic acids |
Peripheral arterial disease, Diabetic peripheral neuropathy |
HGF |
Candidate |
G&P Bioscience |
HN21C0644 |
|